Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Lungpacer Press Release
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
STARI will investigate continual diaphragm neurostimulation to improve lung, diaphragm, cardiac and brain function at the earliest stages of mechanical ventilation
Read The Article
Lungpacer Press Release
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
Read The Article
Lungpacer Featured In
After Tragedy, an Entrepreneur’s Triumph
Brian Gormley of the Wall Street Journal publishes article on Lungpacer’s 15-year journey from a deeply personal mission
Read The Article
Sort by:
Part I: Lungpacer Medical’s diaphragm neurostimulation
February 28, 2025
News
Lungpacer Medical Shares Promising Results from STIMULUS Trial
February 20, 2025
News
Data backs Lungpacer Medical’s diaphragm neurostim
February 20, 2025
News
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
February 20, 2025
Press Release
Lungpacer Medical Announces Premarket Approval for AeroPace® System
December 5, 2024
Press Release
Lungpacer publishes data in Communications Medicine indicating that Lungpacer AeroNova Therapy restores brain activity, connectivity, and synchronization in sedated mechanically-ventilated patients with acute respiratory distress syndrome (ARDS)
November 19, 2024
News
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 4, 2024
Press Release
Lungpacer Medical’s Lead Research Scientist Thiago Bassi, MD, PhD presents data at the 2024 MHSRS (Military Health System Research Symposium)
August 28, 2024
News
Lungpacer publishes research in American Journal of Respiratory and Critical Care Medicine (ATS Journals) on Ventilator-Associated Brain Injury (VABI)
August 20, 2024
News
